Estimates Revisions Turn Therapeutics Inc.
Stocks
TTRX
US90021W1053
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 13.33 USD | +0.15% |
|
+6.73% | +238.32% |
| 09-20 | Turn Therapeutics Inc.(NasdaqGM:TTRX) added to S&P TMI Index | CI |
| 09-09 | Turn Therapeutics Inc. Announces Appointment of Robert R. Redfield as Chief Scientific Officer | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- TTRX Stock
- Consensus Turn Therapeutics Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
